These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 140959)

  • 1. [The investigation of a low molecular acid stable proteinase inhibitor in the middle ear secretion (author's transl)].
    Kastenbauer ER; Hochstrasser K; Reichert R; Brohr T
    Laryngol Rhinol Otol (Stuttg); 1977 Mar; 56(3):201-6. PubMed ID: 140959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental investigations on the proportional inhibitory capacity of different proteinase inhibitors in cases of chronic otitis media and cholesteatoma (author's transl)].
    Kastenbauer ER; Hochstrasser K
    Laryngol Rhinol Otol (Stuttg); 1978 Oct; 57(10):869-71. PubMed ID: 82895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental studies on the reaction of the immunological system during chronic otitis media and about the course of this disease (author's transl)].
    Kastenbauer ER; Hochstrasser K
    Laryngol Rhinol Otol (Stuttg); 1976 Jan; 55(1):36-42. PubMed ID: 60682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of ear surgery to the immunologic defense system of the middle ear during chronic otitis media (author's transl)].
    Kastenbauer ER; Hochstrasser K; Brohr T
    Laryngol Rhinol Otol (Stuttg); 1976 Oct; 55(10):804-12. PubMed ID: 63098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of split products of the immunoglobulins IgG, IgA and IgM during chronic otitis media (author's transl)].
    Kastenbauer ER; Hochgesand K; Hochstrasser K; Tappermann G
    Laryngol Rhinol Otol (Stuttg); 1975 Jul; 54(7):604-11. PubMed ID: 129630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental studies on the question of the enzymatic destruction of the ossicular bones during middle ear inflammations (author's transl)].
    Hochgesand K; Kastenbauer E; Hochstrasser K
    Laryngol Rhinol Otol (Stuttg); 1976 Mar; 55(3):206-9. PubMed ID: 135146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Enzymatic and immunological inflammatory reactions in the middle ear (author's transl)].
    Kastenbauer ER
    Laryngol Rhinol Otol (Stuttg); 1975 Mar; 54(3):177-82. PubMed ID: 123983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease inhibitors in middle ear effusions from experimental otitis media with effusion: kinetics of alpha 1-antitrypsin and alpha 2-macroglobulin levels.
    Hamaguchi Y; Juhn SK; Sakakura Y
    Ann Otol Rhinol Laryngol; 1989 Apr; 98(4 Pt 1):287-92. PubMed ID: 2468303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical study of protease inhibitors in experimental otitis media with effusion.
    Juhn SK; Hamaguchi Y
    Ann Otol Rhinol Laryngol Suppl; 1988; 132():10-3. PubMed ID: 2454602
    [No Abstract]   [Full Text] [Related]  

  • 10. Protease inhibitors in middle ear effusions.
    Carlsson B; Lundberg C; Ohlsson K
    Ann Otol Rhinol Laryngol; 1981; 90(1 Pt 1):38-41. PubMed ID: 6162410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of protease activity in human otitis media.
    Avidano MA; Cotter CS; Stringer SP; Schultz GS
    Otolaryngol Head Neck Surg; 1998 Oct; 119(4):346-51. PubMed ID: 9781988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of antileukoprotease in middle ear mucosa.
    Carlsson B; Ohlsson K
    Acta Otolaryngol; 1983; 95(1-2):111-6. PubMed ID: 6829291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of protease inhibitors in the pathogenesis of otitis media with effusion.
    Hamaguchi Y; Majima Y; Ukai K; Sakakura Y; Miyoshi Y
    Auris Nasus Larynx; 1985; 12 Suppl 1():S145-7. PubMed ID: 3835890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
    Sanković-Babić S; Sofronić-Milosavljević Lj
    Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inter-alpha-trypsin inhibitor as precursor of the acid-stable proteinase inhibitors in human serum and urine.
    Hochstrasser K; Bretzel G; Feuth H; Hilla W; Lempart K
    Hoppe Seylers Z Physiol Chem; 1976 Feb; 357(2):153-62. PubMed ID: 3463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Otitis media and chronic middle ear effusion in the asthmatic pediatric patient.
    Gamble JE; Bizal JA; Daetwyler EP
    Ear Nose Throat J; 1992 Sep; 71(9):397-9. PubMed ID: 1425378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of toll-like receptors in chronic otitis media and cholesteatoma.
    Hirai H; Kariya S; Okano M; Fukushima K; Kataoka Y; Maeda Y; Nishizaki K
    Int J Pediatr Otorhinolaryngol; 2013 May; 77(5):674-6. PubMed ID: 23380629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Operative therapy for chronic otitis media and middle ear cholesteatoma with preservation of the posterior auditory canal wall ("intact wall technique") (author's transl)].
    Tos M
    HNO; 1978 Jul; 26(7):217-23. PubMed ID: 681183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mastocytes in chronic inflammation of middle ear mucosa].
    Sanković S; Dergenc R; Bojić P
    Srp Arh Celok Lek; 1999; 127(1-2):35-8. PubMed ID: 10377839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma in suppurative otitis media: significance of otorrhoea type and disease outcome.
    Lasisi AO; Olayemi O; Arinola OG; Omilabu SA
    J Laryngol Otol; 2009 Oct; 123(10):1103-7. PubMed ID: 19640314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.